The global healthcare CRO market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing number of clinical trials and rising demand for outsourcing clinical research services. The early phase development segment is expected to account for the largest share in the global healthcare CRO market during the forecast period, followed by consulting services and laboratory segment. Biopharmaceutical companies are expected to be the major end-user of healthcare CROs in North America, while academic and research institutes are anticipated to be major end-users in Europe.
Some Of The Growth Factors Of This Market:
- The increasing number of clinical trials and the need for more efficient drug development are the major drivers for the growth of this market.
- Increasing government funding for research and development, rising demand for personalized medicine, and growing awareness about health issues are also driving factors in this market.
- The lack of skilled professionals in the industry is a major challenge faced by this market.
- Increasing adoption of cloud computing technology will provide opportunities to healthcare CROs.
Industry Growth Insights published a new data on “Healthcare CRO Market”. The research report is titled “Healthcare CRO Market research by Types (Early Phase Development, Clinical Research, Laboratory, Consulting Services), By Applications (Biopharmaceutical Companies, Academic and Research Institutes, Others), By Players/Companies Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories, INC Research Holdings, Wuxi PharmaTech”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Healthcare CRO Market Research Report
By Type
Early Phase Development, Clinical Research, Laboratory, Consulting Services
By Application
Biopharmaceutical Companies, Academic and Research Institutes, Others
By Companies
Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories, INC Research Holdings, Wuxi PharmaTech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Healthcare CRO Market Report Segments:
The global Healthcare CRO market is segmented on the basis of:
Types
Early Phase Development, Clinical Research, Laboratory, Consulting Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quintiles Transnational Holdings
- Laboratory Corporation Of America Holdings
- Pharmaceutical Product Development
- PAREXEL International
- ICON plc
- PRA Health Sciences
- InVentiv Health
- Charles River Laboratories
- INC Research Holdings
- Wuxi PharmaTech
Highlights of The Healthcare CRO Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Early Phase Development
- Clinical Research
- Laboratory
- Consulting Services
- By Application:
- Biopharmaceutical Companies
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Healthcare CRO Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Healthcare CRO is a term used to describe the practice of marketing and selling healthcare products and services. Healthcare CRO professionals work with clients to identify opportunities, develop strategies, and execute plans that will help them increase sales of their products or services.
Some of the key players operating in the healthcare cro market are Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories, INC Research Holdings, Wuxi PharmaTech.
The healthcare cro market is expected to register a CAGR of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Healthcare CRO Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Healthcare CRO Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Healthcare CRO Market - Supply Chain
4.5. Global Healthcare CRO Market Forecast
4.5.1. Healthcare CRO Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Healthcare CRO Market Size (000 Units) and Y-o-Y Growth
4.5.3. Healthcare CRO Market Absolute $ Opportunity
5. Global Healthcare CRO Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Healthcare CRO Market Size and Volume Forecast by Type
5.3.1. Early Phase Development
5.3.2. Clinical Research
5.3.3. Laboratory
5.3.4. Consulting Services
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Healthcare CRO Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Healthcare CRO Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. Academic and Research Institutes
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Healthcare CRO Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Healthcare CRO Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Healthcare CRO Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Healthcare CRO Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Healthcare CRO Demand Share Forecast, 2019-2029
9. North America Healthcare CRO Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Healthcare CRO Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Healthcare CRO Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. Academic and Research Institutes
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Healthcare CRO Market Size and Volume Forecast by Type
9.7.1. Early Phase Development
9.7.2. Clinical Research
9.7.3. Laboratory
9.7.4. Consulting Services
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Healthcare CRO Demand Share Forecast, 2019-2029
10. Latin America Healthcare CRO Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Healthcare CRO Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Healthcare CRO Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. Academic and Research Institutes
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Healthcare CRO Market Size and Volume Forecast by Type
10.7.1. Early Phase Development
10.7.2. Clinical Research
10.7.3. Laboratory
10.7.4. Consulting Services
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Healthcare CRO Demand Share Forecast, 2019-2029
11. Europe Healthcare CRO Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Healthcare CRO Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Healthcare CRO Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. Academic and Research Institutes
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Healthcare CRO Market Size and Volume Forecast by Type
11.7.1. Early Phase Development
11.7.2. Clinical Research
11.7.3. Laboratory
11.7.4. Consulting Services
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. MarketAttractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Healthcare CRO Demand Share, 2019-2029
12. Asia Pacific Healthcare CRO Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Healthcare CRO Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Healthcare CRO Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. Academic and Research Institutes
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Healthcare CRO Market Size and Volume Forecast by Type
12.7.1. Early Phase Development
12.7.2. Clinical Research
12.7.3. Laboratory
12.7.4. Consulting Services
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Healthcare CRO Demand Share, 2019-2029
13. Middle East & Africa Healthcare CRO Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Healthcare CRO Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Healthcare CRO Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. Academic and Research Institutes
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Healthcare CRO Market Size and Volume Forecast by Type
13.7.1. Early Phase Development
13.7.2. Clinical Research
13.7.3. Laboratory
13.7.4. Consulting Services
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Healthcare CRO Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Healthcare CRO Market: Market Share Analysis
14.2. Healthcare CRO Distributors and Customers
14.3. Healthcare CRO Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Quintiles Transnational Holdings
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Laboratory Corporation Of America Holdings
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pharmaceutical Product Development
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PAREXEL International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ICON plc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PRA Health Sciences
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. InVentiv Health
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Charles River Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. INC Research Holdings
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Wuxi PharmaTech
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook